Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model

Published:2010-09 Issue:41 Volume:28 Page:6757-6764
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sorensen Maria R.,Holst Peter J.,Steffensen Maria A.,Christensen Jan P.,Thomsen Allan R.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference41 articles.

1. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice;Ohashi;Cell,1991

2. Virus-based immunotherapy of cancer: what do we know and where are we going?;Sorensen;APMIS,2007

3. CD40 and CD154 in cell-mediated immunity;Grewal;Annu Rev Immunol,1998

4. Help for cytotoxic-T-cell responses is mediated by CD40 signalling;Bennett;Nature,1998

5. CD40/CD154 interactions at the Interface of Tolerance and Immunity;Quezada;Annu Rev Immunol,2004

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer;Frontiers in Immunology;2023-04-26

2. Self-assembling peptides as immunomodulatory biomaterials;Frontiers in Bioengineering and Biotechnology;2023-03-01

3. Nanomaterials‐Mediated Co‐Stimulation of Toll‐Like Receptors and CD40 for Antitumor Immunity;Advanced Materials;2022-10-17

4. Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma;Frontiers in Immunology;2022-08-25

5. Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity;Frontiers in Oncology;2022-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3